Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients

(1) Background: Endocan is a marker of endothelial dysfunction that may be associated with thrombotic events. The aim of the study was to investigate the performance of endocan as a marker of thrombotic events in COVID-19 patients. (2) Methods: We measured endocan in plasma from 79 documented COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chenevier-Gobeaux, Camille, Ducastel, Morgane, Meritet, Jean-François, Ballaa, Yassine, Chapuis, Nicolas, Pene, Frédéric, Carlier, Nicolas, Roche, Nicolas, Szwebel, Tali-Anne, Terrier, Benjamin, Borderie, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572304/
https://www.ncbi.nlm.nih.gov/pubmed/36233427
http://dx.doi.org/10.3390/jcm11195560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572304/
https://www.ncbi.nlm.nih.gov/pubmed/36233427
http://dx.doi.org/10.3390/jcm11195560

Ejemplares similares